ArticleScientific reports2025
Ciprofloxacin pre-exposure influences individual cell MIC and heteroresistance of bacteria inside microfluidic droplets.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bacterial cells in general present different phenotypes even within the monoclonal populations. Some phenotypes may offer selective advantages under antibiotic stress. In clinical practice such advantage may lead to selection of resistant phenotypes and to treatment failure. Improving treatment regimens thus requires thorough understanding of the underlying cause of developing phenotypic variations within bacterial populations exposed to antibiotics. Here, we use droplet microfluidics to study the response of individual bacterial cells. We investigate how a short-term exposure of ciprofloxacin or streptomycin at the sub-minimum inhibitory concentration levels changes the single-cell distribution of susceptibility on subsequent exposure to either of the antibiotics. We used three different concentrations of pre-exposure for each antibiotic on Escherichia coli MG1655 and followed with re-exposure of the same bacterial cells individually in microfluidic droplets. Experiments with various concentrations of re-exposure on single cells showed that pre-exposures to sub-lethal levels of ciprofloxacin can elevate the individual cell MIC and the level of heteroresistance to ciprofloxacin. Exposure to quarter and half MIC of ciprofloxacin in separate experiments increased the heteroresistance of pre-exposed cells by more than 20-fold on subsequent treatment with ciprofloxacin. Interestingly, the same ciprofloxacin pre-exposure pattern made the cells more fragile and, in some cases, decreased the individual MIC values to streptomycin. The results in our study can be very important in developing new better treatment regimen, addressing the wider problem of antibiotic resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.